Twist Bioscience Corporation
TWSTTwist Bioscience is a life sciences company that has developed a proprietary silicon-based DNA synthesis platform to industrialize the engineering of biology.
Earnings
Next report
Nov 12, 2026 (In 1 week)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Twist Bioscience is a life sciences company that has developed a proprietary silicon-based DNA synthesis platform to industrialize the engineering of biology. By miniaturizing chemical reactions on a silicon chip, the company manufactures high-quality synthetic DNA, RNA, and proteins at a significantly higher throughput and lower cost than traditional methods. Their technology serves as a foundational tool for innovation in healthcare, agriculture, industrial chemicals, and academic research.
Twist is a leading disruptor in DNA synthesis, utilizing a proprietary silicon-based 'writing' technology that offers superior scale and cost-efficiency compared to legacy plate-based manufacturers.
FAQ
- What is Twist Bioscience Corporation's market cap?
- Twist Bioscience Corporation (TWST) has a market capitalization of $11.5B and trades on NASDAQ.
- What is Twist Bioscience Corporation's revenue and profitability?
- Twist Bioscience Corporation generated $431.8M in trailing twelve-month revenue with a net loss of $136.7M, representing a net margin of -31.7%. Gross margin stands at 52.0%, with free cash flow of -$93.1M. The latest reported period is Q3 2026.
- Who are Twist Bioscience Corporation's competitors?
- Twist Bioscience Corporation's key competitors include Illumina, Inc., Agilent Technologies, Inc., Integrated DNA Technologies, Inc., and others. These companies compete in similar markets and product categories.
- Who does Twist Bioscience Corporation partner with?
- Twist Bioscience Corporation's notable partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, and others.
- Where is Twist Bioscience Corporation headquartered?
- Twist Bioscience Corporation is headquartered in United States of America and employs approximately 919 people. It has been publicly traded since 2018.
